Advair or Seretide
donair Diskus and Advair HFA, has been approved for adult patients with Bronchial Asthma and Chronic Obstructive Pulmonary Disease (COPD).
04
Sep
Tag Archives: Dose
02
Sep
Eliquis or The Selective Factor Xa Inhibitor
Apixaban with the trade name Eliquis is an orally active, reversible, selective factor Xa inhibitor. Specialist indicates this medication for the treatment of venous thromboembolic events that are taken by mouth.
This anticoagulant prevents thrombin generation and thrombus formation; it decreases the conversion of prothrombin to thrombin. After approval in 2012, Pfizer and Bristol-Myers Squibb developed Apixaban in a joint venture. Apixaban is the third novel oral anticoagulant approved in the U.S. for the management of thromboembolic disease.